Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index-Reference-Cited by-同舟云学术

Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index

Published:2016-01 Issue:1 Volume:22 Page:125-133
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bashey Asad,Zhang Xu,Jackson Katelin,Brown Stacey,Ridgeway Michelle,Solh Melhem,Morris Lawrence E.,Holland H. Kent,Solomon Scott R.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference23 articles.

1. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide;O'Donnell;Biol Blood Marrow Transplant,2002

2. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

3. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts;Brunstein;Blood,2011

4. Improved early outcomes using a T cell–replete graft compared with T cell–depleted haploidentical hematopoietic stem cell transplantation;Ciurea;Biol Blood Marrow Transplant,2012

5. T cell–replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation;Bashey;J Clin Oncol,2013

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD;Cells;2024-09-11

2. Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults;JACC: CardioOncology;2024-08

3. Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin;Transplantation and Cellular Therapy;2024-03

4. New Approaches for the Treatment of AML beyond the 7+3 Regimen: Current Concepts and New Approaches;Cancers;2024-02-05

5. Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study;Stem Cell Research & Therapy;2024-01-29